✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Pediatric EpilepsyCbdEpidiolexDrug AccessPharmaceutical Why This MattersJazz Pharmaceuticals develops Epidiolex (cannabidiol), the only FDA-approved cannabis-derived...
New study suggests medical marijuana may not help anxiety and depression – YouTube
✦ New CED Clinical Relevance #86High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic AnxietyDepressionMental HealthClinical EvidenceCbd Why This MattersClinicians need evidence-based guidance on cannabis for anxiety...
Nexalis (formerly InhaleRx) initiates Phase 1 trial of IRX-616a CBD MDI – OINDP News
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic CbdDrug DeliveryPharmacokineticsClinical TrialsRespiratory Why This MattersThe development of a metered-dose inhaler (MDI) for...
Can CBD Cause Gynaecomastia? Evidence, Hormones, and Safe Use – Bolt Pharmacy
✦ New CED Clinical Relevance #60Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Endocrine EffectsCbdAdverse EventsMale HealthDrug Safety Why This MattersGynecomastia concerns with CBD could influence prescribing...
Medicare’s Cannabis (CBD) Coverage Plan Sparks Federal Controversy-Is CMS … – Yahoo Finance
✦ New CED Clinical Relevance #82High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic MedicareCbdPolicyAccessFederal Regulation Why This MattersMedicare coverage decisions directly affect clinical practice patterns and...
Up in smoke: Ohio rolls back some weed and hemp laws and adds new restrictions
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisHempCbdPatient Access Why This MattersOhio's regulatory rollbacks create immediate clinical uncertainty around patient...
Expert: A CBD product ban is unnecessary if regulation is in place on all intoxicating …
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic CbdRegulationHemp ProductsPolicyProduct Safety Why This MattersRegulatory uncertainty around CBD products directly affects patient...
CBD And CBG From The Cannabis Plant Could Help Treat A Common Liver Condition | IFLScience
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Liver DiseaseCbdCbgPreclinical ResearchNafld Why This MattersNon-alcoholic fatty liver disease affects nearly 25% of US...
New York approves cannabis for anxiety. Science says it may not help – Times Union
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic AnxietyMental HealthPolicyCbdClinical Evidence Why This MattersNew York's approval of cannabis for anxiety represents a...
Unleashing Calm: A Complete Guide to Finding the Best CBD Gummies for Relaxation
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdAnxietyConsumer ProductsDosingPatient Education Why This MattersConsumer guides for CBD products often lack clinical rigor,...